Ginsenoside Rb1 improves human nonalcoholic fatty liver disease with liver organoids-on-a-chip.

Autor: Hui Wang1, Yue Zhu1, Pengcheng Shi2, Xiangyang Li2, Qingyun Bu2,3, Yachun Li2, Xiaoyan You1,2 xiaoyanyou@haust.edu.cn, Guoping Zhao1,4,5,6 gpzhao@sibs.ac.cn
Zdroj: Engineered Regeneration. Sep2024, Vol. 5 Issue 3, p283-294. 12p.
Databáze: Academic Search Ultimate